VASO.OQXVaso CORP

DEFA14A: VASO Corporation Files Pro Forma Financials Following Proposed Business Combination with Achari Ventures

Sentiment:

Form 8-K Filing with Pro Forma Financial Information


VASO Corporation released unaudited pro forma condensed combined financial information related to its business combination with Achari Ventures Holdings Corp. I, providing a hypothetical view of the combined entity's financials.

Summary

  • VASO Corporation filed a Form 8-K including unaudited pro forma condensed combined financial information for the six months ended June 30, 2024, and the year ended December 31, 2023.
  • This information simulates the financial results if the business combination with Achari Ventures Holdings Corp. I and Achari Merger Sub, Inc. had been completed on January 1, 2023.
  • The pro forma financial information is for informational purposes only and does not guarantee future results.
  • The business combination is expected to be accounted for as a reverse recapitalization, with Achari treated as the acquired company.
  • The pro forma statements include adjustments for the reclassification of cash held in the Trust Account, payment of deferred underwriter discounts, and the elimination of Achari's historical accumulated deficit.
  • Two scenarios are presented: one assuming no redemptions by public stockholders and another assuming maximum redemptions of 309,010 public shares at $11.51 per share as of June 30, 2024.
  • The pro forma net loss per share for the six months ended June 30, 2024, is $(0.08) under both no redemption and maximum redemption scenarios, assuming no reverse stock split.
  • For the year ended December 31, 2023, the pro forma net loss per share is $(0.04) under both scenarios, assuming no reverse stock split.
  • The likelihood of a reverse stock split is deemed uncertain by Achari and Vaso.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The document primarily presents financial information related to a proposed business combination. While the pro forma statements show a net loss, the document is factual and does not express strong positive or negative views.

Positives

  • The filing provides transparency into the potential financial structure of the combined company.
  • The pro forma statements offer insights into how the business combination could impact VASO's financials.
  • The document includes detailed notes explaining the adjustments made in the pro forma statements.

Negatives

  • The pro forma financial information is hypothetical and does not guarantee future results.
  • The pro forma statements show a net loss per share for both the six months ended June 30, 2024, and the year ended December 31, 2023, under both redemption scenarios.
  • The likelihood of a reverse stock split adds uncertainty to the future capital structure.

Risks

  • The actual financial results of the combined company may differ materially from the pro forma information.
  • The reverse stock split, if implemented, could impact the stock price and shareholder value.
  • The business combination is subject to various closing conditions and may not be completed.
  • Maximum redemptions by Achari's public stockholders could reduce the cash available to the combined company.

Future Outlook

The pro forma financial information is not intended to project the future results of operations that the combined company may achieve after the Business Combination.

Management Comments

  • Achari and Vaso believe that the trading price of Vasos common stock on the over-the-counter market does not currently reflect either the value to Vaso of consummating the Business Combination or the value of Vasos business itself.
  • This belief may be misplaced.

Industry Context

The announcement reflects a trend of companies seeking business combinations to access public markets, particularly in the technology and healthcare sectors. SPAC mergers have become a common route, though subject to increased scrutiny and market volatility.

Comparison to Industry Standards

  • It is difficult to compare VASO's pro forma results directly to industry standards without knowing the specific industry segment in which it primarily operates (IT services, professional sales, or equipment sales).
  • However, SPAC mergers often involve companies with high growth potential but limited historical financial data, making comparisons challenging.
  • Comparable companies in similar sectors (e.g., IT services) often trade at multiples of revenue or EBITDA, which could be used to assess the potential valuation of the combined company post-merger.

Stakeholder Impact

  • Shareholders of Achari and Vaso will be impacted by the business combination and the potential reverse stock split.
  • Employees of both companies may experience changes as a result of the merger.
  • Customers and suppliers of Vaso may be affected by the combined company's strategy and operations.

Next Steps

  • The business combination is subject to customary closing conditions.
  • Achari and Vaso need to complete the merger by October 19, 2024.
  • The combined company may need to consider a reverse stock split depending on the trading price of VASO's common stock.

Key Dates

DateDescription
December 6, 2023Achari, Merger Sub, and Vaso entered into the Business Combination Agreement.
December 18, 2023Achari held a Special Meeting to extend the date to complete a business combination from January 19, 2024, to July 19, 2024; $1.0 million was utilized from the Trust Account to pay redeeming shareholders.
January 1, 2023Pro forma financial statements assume the business combination occurred on this date.
June 30, 2024Date of the unaudited pro forma condensed combined balance sheet.
July 16, 2024Achari held a special meeting to extend the date to complete a business combination from July 19, 2024, to October 19, 2024; $2.8 million was utilized from the Trust Account to pay redeeming shareholders.
August 7, 2024Vaso filed a Definitive Proxy Statement on Schedule 14A covering the proposed business combination.
August 8, 2024Acharis audited statement of operations for the year ended December 31, 2023 and the related notes included in the joint proxy statement/prospectus filed on Form 424 with the SEC.
August 13, 2024Acharis unaudited balance sheet as of June 30, 2024 and the related notes included in Acharis current report on Form 10-Q filed with the U.S. Securities and Exchange Commission (the SEC).
August 14, 2024Achari and Vaso filed their periodic reports on Form 10-Q containing their unaudited financial statements for the three and six months ended June 30, 2024.
August 23, 2024Date of the Form 8-K filing.
October 19, 2024Extended date by which Achari must complete a business combination.

Keywords

business combination, pro forma, financial information, reverse recapitalization, redemption, reverse stock split, VASO Corporation, Achari Ventures, merger

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.